BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17384083)

  • 1. Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide.
    Perkins WJ; Taniguchi M; Warner DO; Chini EN; Jones KA
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L84-95. PubMed ID: 17384083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.
    Perkins WJ; Kost S; Danielson M
    Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L666-73. PubMed ID: 19181745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.
    Perkins WJ; Warner DO; Jones KA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jan; 296(1):L121-9. PubMed ID: 18952758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulation.
    Kwak YL; Jones KA; Warner DO; Perkins WJ
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L200-8. PubMed ID: 16113048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: a possible role for cGMP responsiveness.
    Taniguchi M; Kwak YL; Jones KA; Warner DO; Perkins WJ
    Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L1018-27. PubMed ID: 16326756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
    Ellis DZ; Dismuke WM; Chokshi BM
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1808-13. PubMed ID: 19074804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.
    Ferrero R; Torres M
    BMC Biochem; 2002 Sep; 3():26. PubMed ID: 12350235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged relaxation consistent with persistent soluble guanylyl cyclase activation in canine pulmonary artery following brief treatment with nitric oxide donors.
    Kwak YL; Jones KA; Warner DO; Perkins WJ
    Life Sci; 2006 Oct; 79(21):2001-9. PubMed ID: 16854434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide.
    Ye L; Liu J; Liu H; Ying L; Dou D; Chen Z; Xu X; Raj JU; Gao Y
    Pflugers Arch; 2013 Feb; 465(2):333-41. PubMed ID: 23143201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble guanylyl cyclase during postnatal porcine pulmonary maturation.
    Moreno L; Gonzalez-Luis G; Cogolludo A; Lodi F; Lopez-Farre A; Tamargo J; Villamor E; Perez-Vizcaino F
    Am J Physiol Lung Cell Mol Physiol; 2005 Jan; 288(1):L125-30. PubMed ID: 15447938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
    Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
    Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands.
    Cabilla JP; Ronchetti SA; Nudler SI; Miler EA; Quinteros FA; Duvilanski BH
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E731-7. PubMed ID: 19141686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
    Bachiller PR; Nakanishi H; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 3A expression is modulated by nitric oxide in rat pulmonary artery smooth muscle cells.
    Busch CJ; Graveline AR; Jiramongkolchai K; Liu H; Sanchez LS; Bloch KD
    J Physiol Pharmacol; 2010 Dec; 61(6):663-9. PubMed ID: 21224496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
    El-Awady MS; Smirnov SV; Watson ML
    Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
    Dai Y; Stuehr DJ
    Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.